Jasper Therapeutics Inc (JSPR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access JSPR Annual Balance Sheets →
This page allows investors to track Jasper Therapeutics Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent7.31
Cash & Short-term Investments7.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets11.57
Equipment/Property/Plant Net4.27
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.21
Operating Lease Right Of Use Asset0.32
Restricted Cash Noncurrent0.42
Total Assets11.80
Liabilities
Accounts Payable, Current AC2.78
Accrued Liabilities, Current1.45
Short-term Debt0.40
Other Liabilities, Current3.22
Taxes Payable0.00
Total Current Liabilities7.85
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent2.54
Operating Lease Liability Current0.76
Operating Lease Liability Noncurrent-
Total Liabilities10.39
Stockholders' Equity
Common Stock Value0.00
Common Stock, Held by Subsidiary etc.30.00
Additional Paid In Capital Common Stock322.01
Retained Earnings / Accumulated Deficit-320.60
Defined Benefit Plan and Other2.54
Other Equity0.00
Common Stockholder's Equity1.41
Total Stockholder's Equity1.41
Liabilities & Stockholder's Equity11.80
4 historic quarters locked

Sign in to unlock the full Jasper Therapeutics Inc balance sheet history.

About Jasper Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-089592

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.